Tyrosine Kinase Inhibitors and the Relationship With Adherence, Costs, and Health Care Utilization in Commercially Insured Patients With Newly Diagnosed Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Tyrosine Kinase Inhibitors and the Relationship With Adherence, Costs, and Health Care Utilization in Commercially Insured Patients With Newly Diagnosed Chronic Myeloid Leukemia

Published:2020-04-16 Issue:7 Volume:43 Page:517-525
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Phuar Hsiao Ling,Begley Charles E.,Chan Wenyaw,Krause Trudy Millard

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference42 articles.

1. Chronic myeloid leukemia;Sawyers;N Engl J Med,1999

2. Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology;Radich;J Natl Compr Canc Netw,2018

3. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

4. BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia;Cuellar;J Oncol Pharm Pract,2018

5. Practical issues surrounding the explosion of tyrosine kinase inhibitors for the management of chronic myeloid leukemia;Mathisen;Blood Rev,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between adherence with oral anticancer medications and short-term health care resource utilization: A 2010-2018 claims-based analysis;Journal of Managed Care & Specialty Pharmacy;2024-04

2. Maximizing the Value of Chronic Myeloid Leukemia Management Using Tyrosine Kinase Inhibitors in the USA: Potential Determinants and Consequences of Healthcare Resource Utilization and Costs, with Proposed Optimization Approaches;Clinical Drug Investigation;2024-01-05

3. Current and emerging tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia in young adults;Expert Opinion on Pharmacotherapy;2023-07-27

4. Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions;Journal of Oncology Pharmacy Practice;2023-04-27

5. A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase;Journal of Hematology & Oncology;2022-07-11